# Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects

> **NCT06277284** · NA · UNKNOWN · sponsor: **Shanghai Mabgeek Biotech.Co.Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** MG-K10 humanized monoclonal antibody injection (prefilled syringe)
- **DRUG:** MG-K10 humanized monoclonal antibody injection（Penicillin bottle）

## Key facts

- **NCT ID:** NCT06277284
- **Lead sponsor:** Shanghai Mabgeek Biotech.Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-23
- **Primary completion:** 2024-01-26
- **Final completion:** 2024-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06277284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06277284, "Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06277284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*